Wyeth (Delisted) MD, chairman, board of directors and AGM

BSE: 500095

Formerly Wyeth Lederle

Last traded ₹1,333.85 on 9 Dec 2014

Delisted on 25 Mar 2015.

How mutual funds voted

Fund houses must disclose how they vote at every meeting of a company they hold.

Mutual fund votes, meeting of 10 Nov 2014, 1 fund house

  • Adoption of financial statements for the year ended 31 March 2014
    1 for0 against
  • Ratify the payment of Rs 0.53 mn as remuneration to RA & Co, Cost Auditors for year ending 31 March 2015
    1 for0 against
  • Reappointment of BSR & Associates LLP as statutory auditors
    1 for0 against
  • Reappointment of KK Maheshwari as an Independent Director for a period of one year
    0 for0 against

    1 abstained

  • Reappointment of Sekhar Natarajan as an Independent Director for a period of one year
    1 for0 against
  • Reappointment of Sunil S Lalbhai as an Independent Director for a period of one year
    0 for0 against

    1 abstained

  • Reappointment of Vivek Dhariwal as director
    1 for0 against
  • To approve the transactions with Pfizer Limited for an amount not exceeding Rs 2 bn in each financial year
    1 for0 against
  • To approve transactions with Pfizer Export Company, Ireland for an amount not exceeding Rs 3 bn in each financial year
    1 for0 against

Mutual fund votes, meeting of 21 Apr 2014, 2 fund houses

  • Approval for the scheme of amalgamation of Wyeth Limited with Pfizer Limited and their respective shareholders and creditors
    1 for0 against
  • Board of Director of Applicant company be and hereby authorized to do all such acts, deeds, matters and things as it may, in its absolute discretion, deem necessary to effectively implement the arrangementMoreLess
    1 for0 against
  • The arrangement as embodied in the scheme of amlagation between Wyeth Ltd and Pfizer Ltd. and their respective shareholders and creditors, be and is hereby approved.
    1 for0 against
1 earlier meeting

Mutual fund votes, meeting of 16 Apr 2014, 2 fund houses

  • Amalgamation of Wyeth and Pfizer with effect from April 1, 2013
    1 for0 against
  • Approval for the scheme of amalgamation of Wyeth Limited with Pfizer Limited and their respective shareholders and creditors
    1 for0 against

Each fund house counted once, from its own disclosure; the reasons are its own words.